Cees Wortel

Private Equity Investor at

Vesalius Biocapital Partners SARL

Health Technology

Consumer Services

Finance

Profile

Cees Wortel currently works at Vesalius Biocapital Partners SARL, as Venture Partner from 2016.
Dr. Wortel also formerly worked at Galapagos NV, as Chief Medical Officer.
Dr. Wortel received his doctorate degree in 1993 from the University of Amsterdam.

Cees Wortel active positions

Companies	Position	Start
Vesalius Biocapital Partners SARL Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners invests in companies located in Europe. The firm targets companies operating in the fields of life science, therapeutics, medical devices and diagnostics sectors. It provides financing for seed, early and later stage capital requirements with an investment size of up to USD 10 million. It acts as a lead & co-investor and acquires majority interest and also takes a seat on the board of directors.	Private Equity Investor	01/01/2016

All active positions of Cees Wortel

Former positions of Cees Wortel

Companies	Position	End
LAKEFRONT BIOTHERAPEUTICS NV	Chief Tech/Sci/R&D Officer	-

See the detail of Cees Wortel's experience

Training of Cees Wortel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Cees Wortel's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Galapagos NV Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology	Health Technology
University of Amsterdam University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vesalius Biocapital Partners SARL Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners invests in companies located in Europe. The firm targets companies operating in the fields of life science, therapeutics, medical devices and diagnostics sectors. It provides financing for seed, early and later stage capital requirements with an investment size of up to USD 10 million. It acts as a lead & co-investor and acquires majority interest and also takes a seat on the board of directors.	Finance